| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1615/CRITREVEUKARGENEEXPR.V7.I3.40 |
| P698 | PubMed publication ID | 9399073 |
| P2093 | author name string | Kalafatis M | |
| Mann KG | |||
| van 't Veer C | |||
| Cawthern KM | |||
| Egan JO | |||
| P433 | issue | 3 | |
| P304 | page(s) | 241-280 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Critical Reviews in Eukaryotic Gene Expression | Q5186666 |
| P1476 | title | The regulation of clotting factors | |
| P478 | volume | 7 |
| Q36003551 | A Deep Insight into the Sialome of Rhodnius neglectus, a Vector of Chagas Disease |
| Q53595426 | A control switch for prothrombinase: characterization of a hirudin-like pentapeptide from the COOH terminus of factor Va heavy chain that regulates the rate and pathway for prothrombin activation. |
| Q37277962 | A list of candidate cancer biomarkers for targeted proteomics |
| Q38817825 | A quantitative systems pharmacology model of blood coagulation network describes in vivo biomarker changes in non-bleeding subjects. |
| Q78630174 | Activation and inactivation of human factor X by proteases derived from Ficus carica |
| Q38048276 | Activity based protein profiling to detect serine hydrolase alterations in virus infected cells |
| Q36773877 | Activity-based protein profiling: the serine hydrolases |
| Q44435259 | Amino Acids Glu323, Tyr324, Glu330, and Val331 of Factor Va Heavy Chain Are Essential for Expression of Cofactor Activity |
| Q37415619 | Amino acid region 1000-1008 of factor V is a dynamic regulator for the emergence of procoagulant activity |
| Q51708222 | Anticoagulant thrombins. |
| Q43238276 | C3, C5, and factor B bind to chitosan without complement activation |
| Q35990040 | Candidate-based proteomics in the search for biomarkers of cardiovascular disease |
| Q33308925 | Characterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics |
| Q38869704 | Characterization of the antithrombotic fingerprint of the branded and copies of the low-molecular-weight enoxaparin using thrombin generation assay |
| Q34949496 | Cleavage at both Arg306 and Arg506 is required and sufficient for timely and efficient inactivation of factor Va by activated protein C. |
| Q41827951 | Coagulation factor Va Glu-96-Asp-111: a chelator-sensitive site involved in function and subunit association |
| Q28749128 | Contribution of Amino Acid Region 659−663 of Factor Va Heavy Chain to the Activity of Factor Xa within Prothrombinase, |
| Q42287626 | Contribution of amino acid region 334-335 from factor Va heavy chain to the catalytic efficiency of prothrombinase |
| Q42042386 | Cooperative regulation of the activity of factor Xa within prothrombinase by discrete amino acid regions from factor Va heavy chain |
| Q47232804 | Exploring the molecular complexity of Triatoma dimidiata sialome |
| Q45885740 | Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency |
| Q36412120 | Factor VIII structure and function |
| Q34569960 | Genome-wide prediction and analysis of human tissue-selective genes using microarray expression data |
| Q38880381 | Identification of proteins involved in inhibition of spheroid formation under microgravity |
| Q50924464 | Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa. |
| Q53675691 | Incorporation of factor Va into prothrombinase is required for coordinated cleavage of prothrombin by factor Xa. |
| Q45866045 | Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood |
| Q44316593 | Inhibition of factor VIIa generation and prothrombin activation by treatment with enoxaparin in patients with unstable angina |
| Q27651260 | Mechanism of the Ca2+-induced Enhancement of the Intrinsic Factor VIIa Activity |
| Q33737022 | Microarray data integration for genome-wide analysis of human tissue-selective gene expression |
| Q38161459 | Modeling thrombin generation: plasma composition based approach |
| Q35181632 | Molecular recognition in the protein C anticoagulant pathway |
| Q45863291 | Peptidomimetic inhibitors for activated protein C: implications for hemophilia management |
| Q74620318 | Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor |
| Q24314863 | Progress in the understanding of the protein C anticoagulant pathway |
| Q35166026 | Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase |
| Q42533684 | Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa. |
| Q44279221 | Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes |
| Q41922890 | Role of the acidic hirudin-like COOH-terminal amino acid region of factor Va heavy chain in the enhanced function of prothrombinase |
| Q36863328 | Safety, Stability and Pharmacokinetic Properties of (super)Factor Va, a Novel Engineered Coagulation Factor V for Treatment of Severe Bleeding. |
| Q32060283 | Screening the molecular surface of human anticoagulant protein C: a search for interaction sites |
| Q43600582 | Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol). |
| Q24290448 | Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region |
| Q47158083 | Spellbinding Effects of the Acidic COOH-Terminus of Factor Va Heavy Chain on Prothrombinase Activity and Function |
| Q27641849 | Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins |
| Q44467155 | Structural requirements for expression of factor Va activity |
| Q44148569 | Targeting thrombin and factor VIIa: design, synthesis, and inhibitory activity of functionally relevant indolizidinones |
| Q40564798 | The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells |
| Q42610978 | The Contribution of Amino Acid Region Asp695-Tyr698 of Factor V to Procofactor Activation and Factor Va Function |
| Q40280737 | The Dual Regulatory Role of Amino Acids Leu480 and Gln481 of Prothrombin |
| Q39646902 | The nature of the stable blood clot procoagulant activities |
| Q53626760 | The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII. |
Search more.